by Hannah Beatrice | Nov 27, 2024 | Healthcare, Innovation Prize
Lutra Health is a software product connecting optometrists with eye surgeons and patients, allowing more patients to get access to the eye care they need in the community without having to visit a hospital. We met co-founder Charles Solanki to hear his story. Charles...
by Hannah Beatrice | Oct 7, 2024 | Climate, Innovation Prize, Portfolio
The Blavatnik Prize for Innovation is a £1m prize fund awarded by QantX to pre-investment startups, providing up to £50,000 in non-dilutive funding and guidance from the QantX team. The prize supports businesses to unlock commercial barriers to their innovative...
by Harry Alexander | Apr 26, 2023 | Innovation Prize
Bristol, 27 April 2023 – QantX is proud to announce three new recipients of the 2023 Blavatnik Prize for Innovation. This prestigious £1m prize fund provides non-dilutive prizes to unlock the commercialisation of innovations across sustainability, healthcare, and AI....
by Harry Alexander | Nov 8, 2022 | Healthcare, Innovation Prize
Existing clinical pathways for eyecare are overwhelmed with the significant backlog of patients in secondary care. Before the C-19 pandemic, four million patients in the UK were referred to hospitals but had not been treated within 18 weeks. Further, a pause on...
by Harry Alexander | Oct 31, 2022 | Innovation, Innovation Prize
QantX has awarded Matthew Bone, CEO of Molydyn, a £25,000 Blavatnik Prize for Innovation to support commercial trials and further development of his newly released Atlas platform. Computational tools have shown extreme benefits for biological sciences and drug...
by Harry Alexander | Oct 6, 2022 | Innovation, Innovation Prize
In July, we soft launched the Blavatnik Prize for Innovation to support founders in the South West to commercialise their technology. The goal of the prize fund is to help bridge the gap between a conceptually proven technology and equity investment, by providing...
